Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 2,826Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Tracleer

02 1Tracleer/ bosentan

PharmaCompass

01

Brand Name : Tracleer

Bosentan

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Tracleer

arrow
2024 ACI Convention
Not Confirmed

Bosentan

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2016 Revenue in Millions : 1,010

2015 Revenue in Millions : 1,200

Growth (%) : -16

blank

02

Brand Name : Tracleer

Bosentan

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Tracleer

arrow
2024 ACI Convention
Not Confirmed

Bosentan

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2017 Revenue in Millions : 403

2016 Revenue in Millions : 1,078

Growth (%) : -63

blank

03

Brand Name : Tracleer

Bosentan

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Tracleer

arrow
2024 ACI Convention
Not Confirmed

Bosentan

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2018 Revenue in Millions : 546

2017 Revenue in Millions : 403

Growth (%) : 35%

blank

04

Brand Name : Tracleer/ bosentan

Bosentan

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Tracleer/ bosentan

arrow
2024 ACI Convention
Not Confirmed

Bosentan

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2019 Revenue in Millions : 341

2018 Revenue in Millions : 546

Growth (%) : -38

blank